These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20586533)

  • 1. Clinical correlates of low serum carnitine levels in hospitalized psychiatric patients.
    Cuturic M; Abramson RK; Moran RR; Hardin JW; Hall AV
    World J Biol Psychiatry; 2011 Feb; 12(1):73-9. PubMed ID: 20586533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine and metabolic correlates in hospitalized psychiatric patients: a follow-through report.
    Cuturic M; Abramson RK; Moran RR; Hardin JW
    J Psychiatr Pract; 2011 Jan; 17(1):35-40. PubMed ID: 21266892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of plasma level determinations for lithium and valproate in routine care of psychiatric inpatients with affective disorders.
    Mann K; Hiemke C; Lotz J; Schmidt LG; Lackner KJ; Bates DW
    J Clin Psychopharmacol; 2006 Dec; 26(6):671-3. PubMed ID: 17110832
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia.
    Suzuki T; Uchida H; Takeuchi H; Nakajima S; Nomura K; Tanabe A; Yagi G; Watanabe K; Kashima H
    Hum Psychopharmacol; 2009 Dec; 24(8):628-38. PubMed ID: 19946935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis.
    Avrahami M; Liwinski T; Eckstein Z; Peskin M; Perlman P; Sarlon J; Lang UE; Amital D; Weizman A
    Psychopharmacology (Berl); 2024 Sep; 241(9):1883-1894. PubMed ID: 38733528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study.
    Moreno FA; Macey H; Schreiber B
    J Clin Psychiatry; 2005 May; 66(5):555-8. PubMed ID: 15986510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of response to valproate in geriatric inpatients.
    Niedermier JA; Nasrallah HA
    Ann Clin Psychiatry; 1998 Dec; 10(4):165-8. PubMed ID: 9988057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Yoshimura R; Shinkai K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2007 Jan; 40(1):9-13. PubMed ID: 17327954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of clozapine with valproic Acid for clozapine-induced obsessive-compulsive symptoms.
    Zink M; Englisch S; Knopf U; Kuwilsky A; Dressing H
    Pharmacopsychiatry; 2007 Sep; 40(5):202-3. PubMed ID: 17874353
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcomes and low-dose levocarnitine supplementation in psychiatric inpatients with documented hypocarnitinemia: a retrospective chart review.
    Cuturic M; Abramson RK; Moran RR; Hardin JW
    J Psychiatr Pract; 2010 Jan; 16(1):5-14. PubMed ID: 20098226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized monitoring of valproate and physician responsiveness to laboratory studies as a quality indicator.
    Luchins DJ; Klass D; Hanrahan P; Qayyum M; Malan R; Raskin-Davis V; Fichtner CG
    Psychiatr Serv; 2000 Sep; 51(9):1179-81. PubMed ID: 10970925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new accurate method for predicting lithium clearance and daily dosage requirements in adult psychiatric patients.
    Abou-Auda HS; Al-Yamani MJ; Abou-Shaaban RR; Khoshhal SI
    Bipolar Disord; 2008 May; 10(3):369-76. PubMed ID: 18402625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can valproic acid be an inducer of clozapine metabolism?
    Diaz FJ; Eap CB; Ansermot N; Crettol S; Spina E; de Leon J
    Pharmacopsychiatry; 2014 May; 47(3):89-96. PubMed ID: 24764199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum carnitine levels and clinical correlates between outpatients and acutely hospitalised individuals with bipolar disorder and schizophrenia: A cross-sectional study.
    Cuturic M; Abramson RK; Breen RJ; Edwards AC; Levy EE
    World J Biol Psychiatry; 2016 Sep; 17(6):475-9. PubMed ID: 27088656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term valproic acid treatment on hematological and biochemical parameters in adolescent psychiatric inpatients: a retrospective naturalistic study.
    Amitai M; Sachs E; Zivony A; Remez R; Ben Baruch R; Amit BH; Kronenberg S; Apter A; Shoval G; Weizman A; Zalsman G
    Int Clin Psychopharmacol; 2015 Sep; 30(5):241-8. PubMed ID: 26020713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.